Message from Norman Rosenblum, INMD Scientific Director
February 2023
On February 7th, 2022, INMD alongside Dutch co-funders (Diabetes Fonds, Health~Holland, and the Netherlands Organisation for Health Research and Development) hosted a mid-term meeting in Magog-Orford, Quebec for the TIMED Consortium – bringing together 40+ researchers, students, patient partners, and private partners from across Canada and the Netherlands. The Consortium (The Right Timing to prevent Type 2 Diabetes: Restoring 24-hour substrate rhythmicity to improve glycemic control by timing of lifestyle factors) is funded through the Netherlands-Canada Type 2 Diabetes Research Consortium, a component of the 100 Years of Insulin: Accelerating Canadian Discoveries to Defeat Diabetes Initiative and led by Principal Investigators Dr. André Carpentier (University of Sherbrooke) and Dr. Patrick Schrauwen (Maastricht University). Teams within the Consortium are looking at the impact of differentially timed lifestyle interventions (namely the timing of food intake, exercise, and sleep) throughout a 24-hour period on the development of T2D in order to develop more effective prevention interventions. They are doing this by conducting three types of studies: physiological, epidemiological, and pragmatic trials – all with patient and private partners engaged at each level.
The meeting kicked off with the Principal Investigators sharing the progress and challenges faced by the Consortium to date; the integration of patient and private partners throughout the research; and the sustainability plans for the Consortium. INMD and our co-funders also led an impact and knowledge mobilization (KM) workshop to support work package teams to consider the scientific, societal, and economic impacts of their research. The researchers were also provided with a KM toolkit for teams to start to develop KM plan for maximizing impact for targeted knowledge user groups.
We look forward to learning about the Consortium’s continued progress and how this may impact on the prevention of diabetes amongst Canadians.
Lastly, I would like to give a special thanks to Dr. André Carpentier and his team for coordinating the meeting in such a beautiful setting, and all our speakers who shared their research and experience.
Norman Rosenblum, MD, FRCPC, FCAHS
Scientific Director
Institute of Nutrition, Metabolism and Diabetes
- Date modified: